Marathon gene? Ancient CMAH mutation may have made us better runners

f c d f e a e aa e f
Eliud Kipchoge wins the Berlin Marathon in record time

When Eliud Kipchoge broke the tape at the Berlin Marathon [in September]—setting a new world record by 78 seconds—he and his fellow marathoners may have had evolution to thank. Or, more specifically, the CMAH gene.

In 1998, Ajit Varki, a biologist at the University of California San Diego (UCSD), helped identify a small variation in humans’ CMAH gene compared to that of chimpanzees. The landmark study was the first to find a genetic difference between us and our closest relatives. While CMAH is present in every member of both species, it remains intact in primates (among many other animals), whereas humans are thought to have lost part of the gene between 2 million and 3 million years ago, rendering it effectively inactive.

Varki and other scientists spent the next two decades studying that ancient tweak to CMAH, linking it to an increased risk of ailments such as muscular dystrophy and heart disease. Now, new research published [September 12] in the journal Proceedings of the Royal Society B added another surprising effect to that list: The gene may have also made humans better long-distance runners. “Ironically,” Varki explained, “the same mutation that increases the risk of these diseases gives us the ability to run.”

Read full, original post: Did a Gene Mutation Help Humans Become Super Runners?

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

ChatGPT-Image-May-7-2026-12_32_36-PM
Viewpoint: The state of U.S. vaccine policy? Dismal nationally, but some states are stepping up.
Screenshot-2026-04-22-at-10.46.29-AM
Viewpoint: How to counter science disinformation? Science journalist offers 12 practical tips
Screenshot-2026-04-13-at-1.39.26-PM
Viewpoint: ‘Safer for children?’ Stonyfield yogurt under fire for deceptive organic marketing
ChatGPT-Image-May-7-2026-12_16_37-PM-2
Viewpoint: Are cancer rates ‘skyrocketing’ as RFK, Jr. and MAHA claim? The evidence says mostly the opposite
the magic of mRNA
Viewpoint: Anti-vax fake ‘turbo cancer’ claims threaten cancer treatment breakthroughs
ChatGPT-Image-May-7-2026-01_23_27-PM-2
Viewpoint: Will AI democratize personalized cancer treatment or fuel medical misinformation?
Defense_Secretary_Ash_Carter_tours_the_Microsoft_Cybercrime_Center_in_Seattle_March_3_2016
How criminals are using AI to target social media users and steal their money and confidential data
artificial intelligence brain think illustration md
Viewpoint — Digital gods and human extinction: Will we be the first species ever to design our own descendants?
Picture1-1
Cooling the planet with balloons: Could a geoengineering gamble slow global warming?
ChatGPT-Image-May-12-2026-08_39_41-PM
GLP podcast: Big Pharma, Big Ag, Big Food—health harming industries or life-saving innovators?
ChatGPT Image May 12, 2026, 01_21_30 PM
How big health brands are funding online medical misinformation 
RFKjr-Tech-Vax-Misinfo
As U.S. officials spread medical misinformation, scientists fact check online
Screenshot-2026-04-23-at-11.00.36-AM
Regulators' dilemma: Thalidomide, Metformin, and the cost of getting drug approvals wrong
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.